Trial Profile
Field Trial of Maternal Influenza Immunization in Asia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Feb 2022
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms Mothers'Gift
- 18 Jan 2022 Status changed from active, no longer recruiting to completed.
- 01 May 2020 Results of a pooled analysis of NCT01430689, NCT01034254 and NCT02465190 published in the Pediatric Infectious Disease Journal
- 13 Feb 2018 Results of a pooled analysis of NCT01430689, NCT01034254 and NCT02465190 (n=10,002) assessing the effect of antenatal influenza vaccination on all-cause severe infant pneumonia, published in the Pediatric Infectious Disease Journal